Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ridwan Alam

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Cancer|March 15, 2021
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomyLamont J Wilkins, Jeffrey J Tosoian, Chad A Reichard, et al.
Cancer Research Communications|March 25, 2025
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic SimilarityRoy Elias, Thomas Nirschl, Michael Rezaee, et al.
The Journal of Urology|April 22, 2025
Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative StudyKhalid Y Alkhatib, Joseph G Cheaib, Maximilian Pallauf, et al.
Urologic Oncology|November 10, 2019
The incidence, predictors, and survival of disappearing small renal masses on active surveillanceArnav Srivastava, Hiten D Patel, Mohit Gupta, et al.
JAMA Network Open|November 18, 2025
MRI Utilization Rates for Veterans at Risk of Prostate CancerMitchell M Huang, Joseph D Nicolas, Ridwan Alam, et al.
The Journal of Urology|September 28, 2017
Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM RegistryAkachimere C Uzosike, Hiten D Patel, Ridwan Alam, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
The Journal of Urology|March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRIMarina Schnauss, Nicole Handa, Ramin Nateghi, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Cancer|March 15, 2021
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomyLamont J Wilkins, Jeffrey J Tosoian, Chad A Reichard, et al.
Cancer Research Communications|March 25, 2025
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic SimilarityRoy Elias, Thomas Nirschl, Michael Rezaee, et al.
The Journal of Urology|April 22, 2025
Active Surveillance vs Primary Intervention for Clinical T1a Kidney Tumors: 12-Year Experience of the Delayed Intervention and Surveillance for Small Renal Masses Prospective Comparative StudyKhalid Y Alkhatib, Joseph G Cheaib, Maximilian Pallauf, et al.
Urologic Oncology|November 10, 2019
The incidence, predictors, and survival of disappearing small renal masses on active surveillanceArnav Srivastava, Hiten D Patel, Mohit Gupta, et al.
JAMA Network Open|November 18, 2025
MRI Utilization Rates for Veterans at Risk of Prostate CancerMitchell M Huang, Joseph D Nicolas, Ridwan Alam, et al.
The Journal of Urology|September 28, 2017
Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM RegistryAkachimere C Uzosike, Hiten D Patel, Ridwan Alam, et al.
The Journal of Urology|April 8, 2020
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate CancerWeranja Ranasinghe, Chad A Reichard, Yaw A Nyame, et al.
Cancer|November 14, 2018
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centersDebasish Sundi, Jeffrey J Tosoian, Yaw A Nyame, et al.
European Urology Oncology|May 11, 2025
Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate CancerNicole Handa, Eric V Li, Jamie Michael, et al.
The Journal of Urology|March 23, 2026
Clinical and Reader Associated Correlates of Clinically Significant MRI-Invisible Prostate Cancer based on Negative MRIMarina Schnauss, Nicole Handa, Ramin Nateghi, et al.
Pageof 10